The effects of weight loss versus weight loss maintenance on sympathetic nervous system activity and metabolic syndrome components

J Clin Endocrinol Metab. 2011 Mar;96(3):E503-8. doi: 10.1210/jc.2010-2204. Epub 2010 Dec 22.

Abstract

Context: Sympathetic nervous system (SNS) overactivity participates in both the pathogenesis and adverse clinical complications of metabolic syndrome (MetS) obesity.

Objective: We conducted a prospective lifestyle intervention trial to compare the effects of active weight loss and extended weight loss maintenance on SNS function and MetS components.

Methods: Untreated subjects (14 males, four females; mean age, 53 ± 1 yr; body mass index, 30.9 ± 0.9 kg/m(2)) who fulfilled Adult Treatment Panel III criteria were randomized to 12-wk hypocaloric diet alone (n = 8) or together with aerobic exercise training (n = 10). This was followed by a 4-month weight maintenance period. Measurements of muscle sympathetic nerve activity (MSNA) by microneurography, whole-body norepinephrine kinetics, substrate oxidation by indirect calorimetry, baroreflex sensitivity, plasma renin activity (PRA), and MetS components were performed.

Results: Body weight decreased by 9.3 ± 0.8% at wk 12 (P < 0.001), and this was maintained. During active weight loss, norepinephrine spillover rate decreased by 23 ± 16% (P = 0.004), MSNA by 25 ± 3 bursts per 100 heartbeats (P < 0.001), and PRA by 0.25 ± 0.09 ng/ml · h (P = 0.007), whereas baroreflex sensitivity increased by 5.2 ± 2.2 msec/mm Hg (P = 0.005). After weight maintenance, beneficial effects of weight loss on norepinephrine spillover rate were preserved, whereas PRA and MSNA rebounded (by 0.24 ± 0.11 ng/ml · h, P = 0.02; and 20 ± 5 bursts/100 heartbeats, P = 0.0003), and baroreflex sensitivity was attenuated.

Conclusions: Divergent effects of successful weight loss maintenance on whole-body norepinephrine spillover rate and MSNA suggest organ-specific differentiation in SNS adaptation to weight loss under conditions of negative vs. stable energy balance.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anthropometry
  • Baroreflex / physiology
  • Body Weight / physiology*
  • Diet, Reducing
  • Energy Intake
  • Exercise Therapy
  • Female
  • Heart / physiology
  • Humans
  • Life Style
  • Male
  • Metabolic Syndrome / diet therapy
  • Metabolic Syndrome / physiopathology*
  • Metabolic Syndrome / therapy*
  • Middle Aged
  • Muscle, Skeletal / blood supply
  • Muscle, Skeletal / innervation
  • Norepinephrine / metabolism
  • Physical Fitness
  • Radioisotope Dilution Technique
  • Regional Blood Flow / physiology
  • Sympathetic Nervous System / physiopathology*
  • Weight Loss / physiology*

Substances

  • Norepinephrine